Antileishmanial and Cytotoxic Activity of Synthetic Aromatic Monoterpens

ABSTRACT: The in vitro activity of synthetic monoterpens were evaluated against promastigotes and amastigotes of L. (V.) panamensis and compared to Glucantime®. Cytotoxic activity was determined against U-937 cells. Seven compounds showed low toxicity to U-937 cells (LC50 >100.0 μg/ml) and four o...

Full description

Autores:
Osorio Durango, Edison
Arango Acosta, Gabriel Jaime
Jaramillo Pérez, Luz Marina
Muñoz Herrera, Diana Lorena
Velez, Iván Darío
Robledo, Sara Maria
Mora Arango, Cristina Lucía
Tipo de recurso:
Article of investigation
Fecha de publicación:
2006
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/36200
Acceso en línea:
https://hdl.handle.net/10495/36200
http://www.latamjpharm.org/
Palabra clave:
Monoterpenos
Monoterpenes
Citotoxinas
Cytotoxins
Enfermedades Endémicas
Endemic Diseases
Leishmania
Leishmania
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
Description
Summary:ABSTRACT: The in vitro activity of synthetic monoterpens were evaluated against promastigotes and amastigotes of L. (V.) panamensis and compared to Glucantime®. Cytotoxic activity was determined against U-937 cells. Seven compounds showed low toxicity to U-937 cells (LC50 >100.0 μg/ml) and four of them were active against amastigotes form (EC50 <60.0 μg/ml). No correlation was found between promastigote and amastigote activities, suggesting again that the chemotherapeutic potential of anti-leishma-nial drugs depend on their action against amastigotes. The 3-isopropyl-2,5-dimethoxy-6-methyl-pheny-lamine (T6) compound was the most active showing activity at concentrations similar to those reached in serum by pentavalent antimonials (13.6 μg/ml) but the 5-isopropyl-4-methoxy-2-methyl-3-nitro-phenol (T4) compound was the most selective for Leishmania rather than mammal cells (SI = 8.7). This study concludes that monoterpen derivatives show promising antileishmanial potential and could be considered as new lead structures in the search for novel antileishmanial drugs.